Clinical Research Directory
Browse clinical research sites, groups, and studies.
CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer
Sponsor: Peking Union Medical College Hospital
Summary
This is a single institute, single-arm, interventional trial to evaluate the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy in patients with locally advanced cervical cancer.
Official title: Concurrent Chemoradiotherapy Followed by Tegafur, Gimeracil and Oteracil Potassium Consolidation Chemotherapy in Patients With Locally Advanced Cervical Cancer: a Single Institute, Prospective, Single-arm Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2020-04-15
Completion Date
2026-04-15
Last Updated
2020-03-19
Healthy Volunteers
No
Conditions
Interventions
Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug)
CCRT followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy